Insiders · XLRN

Sujay Kango

Officer at Acceleron Pharma Inc (XLRN)

Sujay Kango has filed 16 insider reports with the SEC since February 2021, as director at Dianthus Therapeutics, Inc. /DE/ (DNTH), director at MEI Pharma, Inc. (LITS) and director at Infinity Pharmaceuticals, Inc. (INFI) and at 1 more company. Sujay Kango made no open-market purchases or sales in the last 12 months. The latest filing, on May 22, 2026, reports grant or award at Dianthus Therapeutics, Inc. /DE/ (DNTH).

Filings
16
Companies
4
Bought on market
None
Sold on market
$2.31M

Companies where Sujay Kango is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Dianthus Therapeutics, Inc. /DE/ logo
DNTH
Dianthus Therapeutics, Inc. /DE/
Directorsince March 2025$89.55May 22, 2026
MEI Pharma, Inc. logo
LITS
MEI Pharma, Inc.
Directorsince November 20210$0.8565Oct 12, 2023
Infinity Pharmaceuticals, Inc. logo
INFI
Infinity Pharmaceuticals, Inc.
Directorsince March 2022Mar 31, 2022
Acceleron Pharma Inc logo
XLRN
Acceleron Pharma Inc
Officer0$2.31MNov 22, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Sujay Kango.

Compare Sujay Kango with

Other insiders at the same companies

Questions about Sujay Kango

What is Sujay Kango's role at Acceleron Pharma Inc?
Sujay Kango reports to the SEC as officer at Acceleron Pharma Inc (XLRN), according to the latest filing on November 22, 2021. Sujay Kango has also filed as director at Dianthus Therapeutics, Inc. /DE/ (DNTH), director at MEI Pharma, Inc. (LITS) and director at Infinity Pharmaceuticals, Inc. (INFI).
Has Sujay Kango bought or sold stock recently?
The most recent open-market sale was on September 27, 2021: sold 5,000 shares of Acceleron Pharma Inc (XLRN) for $875K at an average of $175.00.
How do I get alerts when Sujay Kango files?
Follow Sujay Kango on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Sujay Kango (SEC CIK 0001336503). Totals count each trade once, skipping amendments whose original is on file, from Feb 3, 2021 on. View on SEC EDGAR